Orally deliverable nanoformulation of liraglutide against type 2 diabetic rat model
N. Senduran, Harlokesh Narayan Yadav, Vishal Kumar Vishwakarma, P. K. Bhatnagar, Pooja Gupta, Jagriti Bhatia, Amit Kumar Dinda
Topics & Concepts
LiraglutideDiabetes mellitusIn vivoMedicinePharmacologyInternal medicineEndocrinologyInsulinStreptozotocinOral administrationType 2 diabetesGlucagon-like peptide-1ChemistryBiologyBiotechnologyNatural Antidiabetic Agents StudiesDiabetes Treatment and ManagementDiabetes Management and Research